{"organizations": [], "uuid": "215751c316855981b192fc3871c9434e979ed423", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-kala-pharmaceuticals-posts-q4-loss/brief-kala-pharmaceuticals-posts-q4-loss-per-share-0-46-idUSASC09TKD", "country": "US", "domain_rank": 408, "title": "BRIEF-Kala Pharmaceuticals Posts Q4 Loss Per Share $0.46", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-26T14:43:00.000+03:00", "replies_count": 0, "uuid": "215751c316855981b192fc3871c9434e979ed423"}, "author": "", "url": "https://www.reuters.com/article/brief-kala-pharmaceuticals-posts-q4-loss/brief-kala-pharmaceuticals-posts-q4-loss-per-share-0-46-idUSASC09TKD", "ord_in_thread": 0, "title": "BRIEF-Kala Pharmaceuticals Posts Q4 Loss Per Share $0.46", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "reuters) - kala pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26, 2018 / 11:45 AM / Updated 11 minutes ago BRIEF-Kala Pharmaceuticals Posts Q4 Loss Per Share $0.46 Reuters Staff March 26 (Reuters) - Kala Pharmaceuticals Inc: * KALA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS * Q4 LOSS PER SHARE $0.46 * Q4 EARNINGS PER SHARE VIEW $-0.37 â€” THOMSON REUTERS I/B/E/S * ENDED 2017 WITH $114.6 MILLION IN CASH * PDUFA TARGET ACTION DATE FOR INVELTYS IS AUGUST 24, 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-26T14:43:00.000+03:00", "crawled": "2018-03-26T15:04:08.045+03:00", "highlightTitle": ""}